All lobbying filings

Health Industry Distributors Association

Health Industry Distributors Association filed a Q1 report for Health Industry Distributors Association on April 16, 2025.

Lobbying for Health Industry Distributors Association

As filed: HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION for HEALTH INDUSTRY DISTRIBUTORS ASSOCIATION.

All filings by Health Industry Distributors Association · Everything Health Industry Distributors Association has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2025

Jan 1 - Mar 31 · Posted Apr 16, 2025

Expenses

$30,000

What this organization spent lobbying with its own staff. Reported using the LDA's own definitions (method A): the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Virginia

Official filing document

Government bodies contacted 11

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025 Medical Supply Chain Resiliency Act (S. 998/HR 2213) Reauthorization of the Pandemic and All-Hazards Preparedness Act (PAHPA) either as standalone legislation or inclusion in a larger package such as S.891, the Bipartisan Health Care Act. Health cybersecurity legislation. Implementation of the Drug Supply Chain Security Act (DSCSA).

Transportation

Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025. S.257, the Promoting Resilient Supply Chains Act of 2025. Implementation of HR 6140, enacted as Section 3522 of Public Law 118-159:Facilitating Access to Swiftly Transport Goods during a Publicly Announced State of Emergency Situation (FAST PASS) Act. Monitoring of labor issues and work stoppages resulting from the International Longshoreman's Association strike affecting ports on the East Coast of the United States.

Tariff (miscellaneous tariff bills)

Linda Rouse O'Neill ceased lobbying for HIDA on 2/7/2025. Legislative and executive branch action with respect to tariffs and tariff exclusions on medical products: including IEEPA reciprocal tariffs, IEEPA border/fentanyl tariffs on China, Mexico and Canada, tariff investigations pursuant to Sec 301 and Sec 232 on medical products. Medical Supply Chain Resiliency Act (S. 998/HR 2213)

Bills named in this filing 5

S. 998
Medical Supply Chain Resiliency Act
H.R. 2213
Medical Supply Chain Resiliency Act
S. 891
Bipartisan Health Care Act
S. 257
Promoting Resilient Supply Chains Act of 2025
H.R. 6140
Congressional Budget Office Scheduling Reform Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.